474 related articles for article (PubMed ID: 11208906)
1. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
[TBL] [Abstract][Full Text] [Related]
2. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.
Zhu X; Ogawa O; Wang Y; Perry G; Smith MA
J Neurochem; 2003 Apr; 85(1):87-93. PubMed ID: 12641730
[TBL] [Abstract][Full Text] [Related]
3. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
5. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
6. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.
Zhu X; Castellani RJ; Takeda A; Nunomura A; Atwood CS; Perry G; Smith MA
Mech Ageing Dev; 2001 Dec; 123(1):39-46. PubMed ID: 11640950
[TBL] [Abstract][Full Text] [Related]
8. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
10. Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.
Ferrer I
Neurotox Res; 2004; 6(6):469-75. PubMed ID: 15658002
[TBL] [Abstract][Full Text] [Related]
11. c-Jun phosphorylation in Alzheimer disease.
Thakur A; Wang X; Siedlak SL; Perry G; Smith MA; Zhu X
J Neurosci Res; 2007 Jun; 85(8):1668-73. PubMed ID: 17455299
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons.
Coffey ET; Smiciene G; Hongisto V; Cao J; Brecht S; Herdegen T; Courtney MJ
J Neurosci; 2002 Jun; 22(11):4335-45. PubMed ID: 12040039
[TBL] [Abstract][Full Text] [Related]
13. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.
Savage MJ; Lin YG; Ciallella JR; Flood DG; Scott RW
J Neurosci; 2002 May; 22(9):3376-85. PubMed ID: 11978814
[TBL] [Abstract][Full Text] [Related]
14. P38 MAP kinase is activated at early stages in Alzheimer's disease brain.
Sun A; Liu M; Nguyen XV; Bing G
Exp Neurol; 2003 Oct; 183(2):394-405. PubMed ID: 14552880
[TBL] [Abstract][Full Text] [Related]
15. Human c-Jun N-terminal kinase expression and activation in the nervous system.
Kumagae Y; Zhang Y; Kim OJ; Miller CA
Brain Res Mol Brain Res; 1999 Apr; 67(1):10-7. PubMed ID: 10101227
[TBL] [Abstract][Full Text] [Related]
16. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
17. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
[TBL] [Abstract][Full Text] [Related]
18. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites.
Trojanowski JQ; Mawal-Dewan M; Schmidt ML; Martin J; Lee VM
Brain Res; 1993 Aug; 618(2):333-7. PubMed ID: 8374766
[TBL] [Abstract][Full Text] [Related]
19. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
